Mobile data services are the next wave of growth for the mobile communications industry amid the increasingly saturated subscriber base. While messaging will continue to be the main revenue contributor in most emerging and developing mobile data markets, much of the growth potential also lies in premium content. Greater 3G (third generation) coverage and deployment, expanding regional subscriber base, declining cost of advanced multimedia handsets, and the race to secure a continuous stream of content through partnerships are likely to drive growth of mobile data revenues.
Studies on lighting have shown that replacing traditional fluorescent lights with the latest energy-saving models can reduce HK$636 million of the electricity costs in Hong Kong's business sector.
JETRO's monthly survey of Japanese companies and affiliates operating in 12 countries/regions of East Asia revealed that overall current sentiment remained subdued in the ASEAN region for the tenth straight month in September
Miners operating in or planning to enter the resources sector in the Asia Pacific will face higher political risk factors than other geographies as a direct result of the impact on the region of globalisation.
Second wave of economic expansion brings a different type of expatriate to China. SIRVA, a relocation services provider, has released the findings of its China Urban Index, a mobility study investigating the suitability of first- and second-tier cities for business operations and expatriate relocations in China.
In fiscal 2006, the year ending March 31, 2007, Hitachi, Ltd.is now forecasting net sales of 9,740.0 billion yen, 40.0 billion yen higher than initial forecasts.
Supply and demand are working together to spur tremendous growth in online travel bookings. A new report by PhoCusWright, "The Emerging Online Travel Marketplace in India," estimates that online leisure/unmanaged business travel gross bookings in India totaled $295 million in 2005 and will grow nearly sevenfold in just three years to go beyond $2.0 billion by 2008.
China has a large and fast-growing pharmaceuticals industry. According the Research and Markets the estimated value of the domestic industry in China, at the end of 2005, will be in the region of RMB288.74bn (US$34.89bn), and will have grown by over 140% since 1998.
